Article
SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer
10 Aug 2021
Abstract excerpt
BACKGROUNDImmune checkpoint inhibitors (ICIs) fail to demonstrate efficacy in pancreatic cancer. Recently, genomic biomarkers have been associated with response to ICIs: microsatellite instability high (MSI-H) and tumor mutation burden (TMB) > 10 mutations/Mb. Alterations in Switch/Sucrose Nonfermentable (SWI/SNF) chromatin remodeling genes may predispose to improved outcomes with immunotherapy. The current study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
